The United States cardiovascular devices market size is expected to grow from US$ 17.68 billion in 2024 to US$ 30.68 billion by 2033 at a compound annual growth rate (CAGR) of 6.32% during the forecast period 2025-2033. This can be attributed to the increasing incidence of cardiovascular diseases, improvement in device technology, increasing adoption of minimally invasive procedures, and rising demand for diagnostic and therapeutic devices across healthcare settings.